Health In Tech, Inc.(HIT)Stock Analysis
AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →13F Pro Quality Score
Rank #2,470 of 2,879 stocks
Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Aug 14, 2026.
Revenue Growth
Profitability
Balance Sheet
Earnings Quality
Free Cash Flow
Institutional Flow
Revenue Scale
Dilution Risk
HIT Stock Analysis & AI Quality Score
AI stock analysis and institutional research for Health In Tech, Inc. (HIT), a Financials sector company. 13F Pro's AI-powered ranking engine scores HIT at 27.4/100 on a 32-signal composite quality model, placing it at rank #2,470 of 2,879 stocks — the bottom half of the AI-ranked universe. HIT scores in the top quartile across institutional flow (97.7). Areas of concern include revenue growth (4.8) and revenue scale (8.7), which score below median versus the broader universe. Shareholder dilution risk is elevated at 26.8/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q1 2026), Health In Tech, Inc. reports quarterly revenue of $8.8M, net income of $-1.6M, free cash flow of $-3.3M. Top institutional holders of HIT by reported 13-F value include Mink Brook Asset Management, VANGUARD CAPITAL MANAGEMENT, HEIGHTS CAPITAL MANAGEMENT,, based on the most recent SEC filings. HIT trades on the Nasdaq exchange and files with the SEC under CIK 2019505. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate HIT daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Health In Tech, Inc. directly from SEC EDGAR.
Revenue
Q1 2026
$8.8M
Net Income
Q1 2026
$-1.6M
Free Cash Flow
Q1 2026
$-3.3M
Revenue & Net Income
Earnings Per Share
Key Financials Over Time
Export Financial Table · Pro+Revenue
+71.0% YoYNet Income
+90.7% YoYEPS (Diluted)
+100.0% YoYTotal Assets
+46.4% YoYOp. Cash Flow
+44.0% YoY| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Revenue | $33.3M +71.0% | $19.5M +1.8% | $19.2M | — |
| Net Income | $1.3M +90.7% | $670.5K | — | — |
| EPS (Diluted) | $0.02 +100.0% | $0.01 | — | — |
| Total Assets | $23.1M +46.4% | $15.8M +37.1% | $11.5M | — |
| Operating Cash Flow | $3.1M +44.0% | $2.2M +42.3% | $1.5M | — |
AI Insight: HIT Ratio Trends
Health In Tech's profitability collapsed across all metrics in Q1 2026, with operating margin plunging to -23.6% from -5.9% in Q4 2025.
• Operating margin deteriorated from 8.9% in Q2 2025 to -23.6% in Q1 2026, signaling severe operational distress.
• ROIC swung sharply negative to -38.3% in Q1 2026 from positive 20.3% in Q2 2025, destroying shareholder value.
• TTM net profit margin of -2.4% reflects mounting losses over the trailing twelve months.
⚠ Quarterly deterioration accelerated Q4 2025 into Q1 2026; investigate whether Q1 represents a bottom or ongoing decline.
⚠ All profitability and return metrics now deeply negative; capital structure risks (D/E unavailable) and cash burn require urgent clarification.
Get alerted when HIT's score changes
Free account: watchlist tracking, the daily AI brief, and the AI screener.
Available Research
13F Pro tracks comprehensive data for Health In Tech, Inc. including:
Top Institutional Holders of HIT
Mink Brook Asset Management LLC
$1.2M806,461 shVANGUARD CAPITAL MANAGEMENT LLC
$819.9K565,475 shHEIGHTS CAPITAL MANAGEMENT, INC
$541.3K373,298 shBlackRock, Inc.
$412.8K284,655 shGEODE CAPITAL MANAGEMENT, LLC
$265.8K183,325 shVANGUARD FIDUCIARY TRUST CO
$108.1K74,568 shSTATE STREET CORP
$91.2K62,900 shTWO SIGMA INVESTMENTS, LP
$75.8K52,306 shCITADEL ADVISORS LLC
$53.1K36,632 shNORTHERN TRUST CORP
$52.4K36,150 sh
| Fund | Value | Shares |
|---|---|---|
| Mink Brook Asset Management LLC | $1.2M | 806,461 |
| VANGUARD CAPITAL MANAGEMENT LLC | $819.9K | 565,475 |
| HEIGHTS CAPITAL MANAGEMENT, INC | $541.3K | 373,298 |
| BlackRock, Inc. | $412.8K | 284,655 |
| GEODE CAPITAL MANAGEMENT, LLC | $265.8K | 183,325 |
| VANGUARD FIDUCIARY TRUST CO | $108.1K | 74,568 |
| STATE STREET CORP | $91.2K | 62,900 |
| TWO SIGMA INVESTMENTS, LP | $75.8K | 52,306 |
| CITADEL ADVISORS LLC | $53.1K | 36,632 |
| NORTHERN TRUST CORP | $52.4K | 36,150 |
More Financials Companies
View all Financials →Put HIT on your watchlist
Track score changes the day Health In Tech, Inc. files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.
Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).
Popular Research
Is HIT a good stock to buy?
13F Pro's AI-powered analysis of Health In Tech, Inc. (HIT) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Financials sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for HIT are available on the HIT stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing.
Which hedge funds own HIT?
Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling HIT. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of Health In Tech, Inc.'s investment landscape.